Optical Coherence Tomography Angiography in Neurological Disease
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Jan 27, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special imaging technique called Optical Coherence Tomography Angiography (OCTA), which uses near-infrared light to take pictures of the blood vessels in the eye. Researchers want to see how well OCTA can help identify problems in the brain, especially in patients who have experienced conditions like strokes or bleeding in the brain. By comparing the OCTA images of patients with these neurological issues to those of healthy individuals, the team hopes to gather important information that could lead to more research in this area.
To participate in this study, individuals must be 18 years or older and have been admitted to the neuroscience intensive care unit for certain conditions, such as subarachnoid hemorrhage or ischemic stroke. However, pregnant women, non-English speakers, and those who cannot follow simple commands will not be eligible. Participants can expect to undergo OCTA imaging while sitting comfortably, and their involvement will help advance understanding of neurological diseases and improve future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Patient admitted to the neuroscience intensive care unit with a diagnosis of: subarachnoid hemorrhage, intracerebral hemorrhage, intracranial aneurysm (ruptured or unruptured), intracranial vascular malformation, ischemic stroke, seizure disorder, intracranial infection, intracranial tumor(s), inflammatory demyelinating disease, traumatic brain injury and/or neuromuscular respiratory failure OR subjects from the community without major neurologic, cardiovascular, pulmonary or metabolic disease
- Exclusion Criteria:
- • Pregnancy
- • Non-English speaking
- • GCS motor score less than 6 (i.e. must be able to follow commands)
- • Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported